Los Angeles General Medical Center — Los Angeles, California

Public research footprint of Los Angeles General Medical Center, compiled from the ClinicalTrials.gov public registry.

210

Registered studies

180

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Urothelial Carcinoma · Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · Metastatic Non-Cutaneous Melanoma · Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT05600894 — Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Los Angeles General Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.